Royalty Pharma (RPRX) Free Cash Flow (QoQ) (2019 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) Free Cash Flow (QoQ) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Orix | 44.91 Bn | 45.24 Bn | 4.68 Bn |
| 2 | Royalty Pharma | 36.78 Bn | 38.89 Bn | - |
| 3 | Royal Gold | 22.19 Bn | 22.06 Bn | 390.45 Mn |
| 4 | OR Royalties | 6.98 Bn | 6.91 Bn | 82.22 Mn |
| 5 | Encore Capital | 2.06 Bn | 1.88 Bn | 455.04 Mn |
| 6 | Atlanticus Holdings | 1.41 Bn | 853.17 Mn | 686.46 Mn |
| 7 | Jefferson Capital | 1.23 Bn | 1.21 Bn | - |
| 8 | Upbound | 1.11 Bn | 1.00 Bn | 594.84 Mn |
| 9 | Lufax Holding | 1.08 Bn | -1.19 Bn | - |
| 10 | Metalla Royalty & Streaming | 957.79 Mn | 946.72 Mn | 4.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.58% |
| Mar 31, 2026 | 184.46% |
| Dec 31, 2025 | 136.05% |
| Sep 30, 2025 | -171.45% |
| Jun 30, 2025 | -39.02% |
| Mar 31, 2025 | 141.77% |
| Dec 31, 2024 | 150.13% |
| Sep 30, 2024 | -597.19% |
| Jun 30, 2024 | -112.17% |
| Mar 31, 2024 | 351.97% |
| Dec 31, 2023 | -287.61% |
| Sep 30, 2023 | -77.64% |
| Jun 30, 2023 | 26.67% |
| Mar 31, 2023 | 35.17% |
| Dec 31, 2022 | 141.12% |
| Sep 30, 2022 | -294.40% |
| Jun 30, 2022 | -13.09% |
| Mar 31, 2022 | 44.61% |
| Dec 31, 2021 | 136.73% |
| Sep 30, 2021 | -346.77% |